Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-04-19
2011-04-19
Graser, Jennifer E (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S185100, C424S190100, C424S193100, C530S350000
Reexamination Certificate
active
07927608
ABSTRACT:
The present invention relates to the field ofStreptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism ofS. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis ofS. suis-associated diseases and infections caused byS. suis.
REFERENCES:
patent: 5610011 (1997-03-01), Smith et al.
Greenspan et al (Nature Biotechnology 7: 936-937, 1999).
Chothia et al (The EMBO Journal, 1986, 5/4:823-26).
Mikayama et al. (Nov. 1993. Proc.Natl.Acad.Sci. USA, vol. 90 : 10056-10060).
Rudinger et al. (Jun. 1976. Peptide Hormones. Biol.Council. pp. 5-7).
Arends, J. P., and H. C. Zanen. 1988. Meningitis caused byStreptococcus suisin humans. Rev Infect Dis 10:131-7.
Arulanandam, B. P., J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity againstStreptococcus pneumoniaeinfection. Infect Immun 69:6718-24.
Berthelot-Herault, F., R. Cariolet, A. Labbe, M. Gottschalk, J. Y. Cardinal, and M. Kobisch. 2001. Experimental infection of specific pathogen free piglets with French strains ofStreptococcus suiscapsular type 2. Can J Vet Res 65:196-200.
Buchanan, R. M., D. E. Briles, B. P. Arulanandam, M. A. Westerink, R. H. Raeder, and D. W. Metzger. 2001. IL-12—mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines. Vaccine 19:2020-8.
Burnette, W. N. 1981. “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate—polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112:195-203.
Crawley, A., and B. N. Wilkie. 2003. Porcine Ig isotypes: function and molecular characteristics. Vaccine 21:2911-22.
Elliott, S. D., F. Clifton-Hadley, and J. Tai. 1980. Streptococcal infection in young pigs. V. An immunogenic polysaccharide fromStreptococcus suistype 2 with particular reference to vaccination againstStreptococcal meningitisin pigs. J Hyg (Lond) 85:275-85.
Galina, L., U. Vecht, H. J. Wisselink, and C. Pijoan. 1996. Prevalence of various phenotypes ofStreptococcus suisisolated from swine in the U.S.A. based on the presence of muraminidase-released protein and extracellular factor. Can J Vet Res 60:72-4.
Gottschalk, M., R. Higgins, M. Jacques, M. Beaudoin, and J. Henrichsen. 1991. Characterization of six new capsular types (23 through 28) ofStreptococcus suis. J Clin Microbiol 29:2590-4.
Gottschalk, M., R. Higgins, M. Jacques, M. Beaudoin, and J. Henrichsen. 1991. Isolation and characterization ofStreptococcus suiscapsular types 9-22. J Vet Diagn Invest 3:60-5.
Gottschalk, M., R. Higgins, M. Jacques, K. R. Mittal, and J. Henrichsen. 1989. Description of 14 new capsular types ofStreptococcus suis. J Clin Microbiol 27:2633-6.
Gottschalk, M., A. Lebrun, H. Wisselink, J. D. Dubreuil, H. Smith, and U. Vecht. 1998. Production of virulence-related proteins by Canadian strains ofStreptococcus suiscapsular type 2. Can J Vet Res 62:75-9.
Gottschalk, M., and M. Segura. 2000. The pathogenesis of the meningitis caused byStreptococcus suis: the unresolved questions. Vet Microbiol 76:259-72.
Higgins, R., and M. Gottschalk. 1998. Distribution ofStreptococcus suiscapsular types in 1997. Can Vet J 39:299-300.
Higgins, R., M. Gottschalk, M. Boudreau, A. Lebrun, and J. Henrichsen. 1995. Description of six new capsular types (29-34) ofStreptococcus suis. J Vet Diagn Invest 7:405-6.
Higgins, R., M. Gottschalk. 2005. Streptococcal diseases (In press). In B. E. Straw, S. D'Allaire, W. L. Mengeling, and D. J. Taylor (9th ed), Diseases of swine. Iowa State University Press, Ames.
Hill, J. E., M. Gottschalk, R. Brousseau, J. Harel, S. M. Hemmingsen, and S. H. Goh. 2005. Biochemical analysis, cpn60 and 16S rDNA sequence data indicate thatStreptococcus suisserotypes 32 and 34, isolated from pigs, areStreptococcus orisratti. Vet Microbiol 107:63-9.
Holt, M. E., M. R. Enright, and T. J. Alexander. 1988. Immunisation of pigs with live cultures ofStreptococcus suistype 2. Res Vet Sci 45:349-52.
Ioannou, X. P., P. Griebel, R. Hecker, L. A. Babiuk, and S. van Drunen Littel-13 van den Hurk. 2002. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol 76:9002-10.
Jacobs, A. A., A. J. van den Berg, and P. L. Loeffen. 1996. Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin ofStreptococcus suis. Vet Rec 139:225-8.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-5.
Lefeber, D. J., B. Benaissa-Trouw, J. F. Vliegenthart, J. P. Kamerling, W. T. Jansen, K. Kraaijeveld, and H. Snippe. 2003. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related toStreptococcus pneumoniaetype 3. Infect Immun 71:6915-20.
Lofthouse, S. A., A. E. Andrews, A. D. Nash, and V. M. Bowles. 1995. Humoral and cellular responses induced by intradermally administered cytokine and conventional adjuvants. Vaccine 13:1131-7.
Lynch, J. M., D. E. Briles, and D. W. Metzger. 2003. Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12, Infect Immun 71:4780-8.
Marques, M. B., D. L. Kasper, A. Shroff, F. Michon, H. J. Jennings, and M. R. Wessels. 1994. Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine. Infect Immun 62:1593-9.
McArthur, J., E. Medina, A. Mueller, J. Chin, B. J. Currie, K. S. Sriprakash, S. R. Talay, G. S. Chhatwal, and M. J. Walker. 2004. Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination ofStreptococcus pyogenesin a murine skin Infection model. Infect Immun 72:7342-5.
Miyaji, E. N., D. M. Ferreira, A. P. Lopes, M. C. Brandileone, W. O. Dias, and L. C. Leite. 2002. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines againstStreptococcus pneumoniaeexpressing PspA fragments from different clades. Infect Immun 70:5086-90.
Nichani, A. K., R. S. Kaushik, A. Mena, Y. Popowych, D. Dent, H. G. Townsend, G. Mutwiri, R. Hecker, L. A. Babiuk, and P. J. Griebel. 2004. CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep. Cell immunol 227:24-37.
Okwumabua, O., O. Abdelmagid, and M. M. Chengappa. 1999. Hybridization analysis of the gene encoding a hemolysin (suilysin) ofStreptococcus suistype 2: evidence for the absence of the gene in some isolates. FEMS Microbiol Lett 181:113-21.
Pallares, F. J., C. S. Schmitt, J. A. Roth, R. B. Evans, J. M. Kinyon, and P. G. Halbur. 2004. Evaluation of a ceftiofur-washed whole cellStreptococcus suisbacterin in pigs. Can J Vet Res 68:236-40.
Perch, B., K. B. Pedersen, and J. Henrichsen. 1983. Serology of capsulated streptococci pathogenic for pigs: six new serotypes ofStreptococcus suis. J Clin Microbiol 17:993-6.
Segura, M., M. Gottschalk, and M. Olivier. 2004. EncapsulatedStreptococcus suisinhibits activation of signaling pathways involved in phagocytosis. Infect Immun 72:5322-30.
Serhir, B., D. Dugourd, M. Jacques, R. Higgins, and J. Harel. 1997. Cloning and characterization of a dextranase gene (dexS) fromStreptococcus suis. Gene 190:257-61.
Sheoran, A. S., S. Artiushin, and J. F. Timoney. 2002. Nasal mucosal Immunogenicity for the horse of a SeM peptide ofStreptococcus equigenetically coupled to cholera toxin. Vaccine 20:1653-9.
Torremorell, M., C. Pijoan, and S. Dee. 1999. Experimental exposure of young pigs using a pathogenic strain ofStreptococcus suisserotype 2 and evaluation of this method for disease prevention. Can J Vet Res 63:269-75.
Trottier, S., R. Hi
Gottschalk Marcelo
Harel Josée
Li Yuanyi
Choate Hall & Stewart LLP
Graser Jennifer E
Lyon Charles E.
Valorisation—Recherche Limited Partnership
LandOfFree
Streptococcus suis polypeptides and polynucleotides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Streptococcus suis polypeptides and polynucleotides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Streptococcus suis polypeptides and polynucleotides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2730209